Vision Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,185
| Closed | -$2.06M | – | 107 |
|
|
2020
Q4 | $2.06M | Buy |
13,185
+311
| +2% | +$48.6K | 0.38% | 54 |
|
|
2020
Q3 | $1.47M | Sell |
12,874
-67
| -0.5% | -$7.67K | 0.31% | 62 |
|
|
2020
Q2 | $1.45M | Sell |
12,941
-694
| -5% | -$77.9K | 0.33% | 60 |
|
|
2020
Q1 | $1.22M | Buy |
13,635
+3,177
| +30% | +$285K | 0.33% | 53 |
|
|
2019
Q4 | $1.13M | Sell |
10,458
-5,678
| -35% | -$614K | 0.26% | 58 |
|
|
2019
Q3 | $1.58M | Buy |
16,136
+5,654
| +54% | +$554K | 0.41% | 50 |
|
|
2019
Q2 | $1.37M | Buy |
10,482
+113
| +1% | +$14.8K | 0.36% | 51 |
|
|
2019
Q1 | $1.4M | Buy |
+10,369
| New | +$1.4M | 0.39% | 51 |
|
|
2015
Q2 | – | Sell |
-62,648
| Closed | -$10.9M | – | 70 |
|
|
2015
Q1 | $10.9M | Sell |
62,648
-19,712
| -24% | -$3.42M | 1.63% | 37 |
|
|
2014
Q4 | $15.2M | Buy |
82,360
+3,647
| +5% | +$675K | 1.75% | 38 |
|
|
2014
Q3 | $13.1M | Sell |
78,713
-3,983
| -5% | -$660K | 1.62% | 38 |
|
|
2014
Q2 | $12.9M | Sell |
82,696
-42,813
| -34% | -$6.69M | 1.54% | 40 |
|
|
2014
Q1 | $19.1M | Sell |
125,509
-4,410
| -3% | -$671K | 2.33% | 28 |
|
|
2013
Q4 | $17.3M | Buy |
129,919
+3,810
| +3% | +$506K | 2.05% | 38 |
|
|
2013
Q3 | $14.6M | Buy |
126,109
+29,409
| +30% | +$3.42M | 1.73% | 40 |
|
|
2013
Q2 | $8.92M | Buy |
+96,700
| New | +$8.92M | 1.43% | 40 |
|